Dr. Ahmed Ghalib Abed Zaid Al Sharefi Consultant Endocrinology
Years of Experience : 14
Nationality : United Kingdom
Languages Known : Arabic, English
Book AppointmentBiography
Dr. Ahmed Al-Sharefi worked as a consultant in internal medicine, endocrinology, and diabetes at South Tyneside and Sunderland NHS Foundation Trust (UK) and served as an honorary consultant in reproductive endocrinology at the Royal Victoria Infirmary in Newcastle, North East England. After completing his M.B.Ch.B. with distinction in Baghdad, he pursued further clinical training in the United Kingdom. He successfully completed the residency program in England and obtained the Certificate of Completion of Training (CCT) in endocrinology, diabetes, and general internal medicine in 2021. He is a member of the Royal College of Physicians of Edinburgh (MRCP-Edinburgh) and was awarded the prestigious Fellowship of the Royal College of Physicians of London (FRCP-London). Throughout his career, he has gained invaluable clinical experience working in various NHS hospitals in the UK, including a research placement at Imperial College London and Hammersmith Hospital in 2019. He has published numerous scientific papers in peer-reviewed journals, including a book chapter on diabetes and lipids published by Oxford University Press. He has also presented his work at several national and international conferences. Dr. Ahmed contributes to the development of national diabetes guidelines as a member of the Joint British Diabetes Society for Inpatient Care Group (JBDS-IP). Moreover, his outstanding achievements have been recognized through various awards, including the Undergraduate Top 10 Students Award, the Kelly-Young Regional Prize, Best Oral Presentation Prize 2016, and the Best Poster Prize at the Obesity Update Conference 2017. Aside from his clinical and research endeavors, Dr. Al-Sharefi is an examiner for the Royal College MRCP PACES exam and is regularly involved in teaching endocrinology courses on a national level, demonstrating his commitment to the education and mentorship of future physicians. Dr. Al-Sharefi A has contributed to numerous endocrinology conferences and journals, including presenting on “The Endocrine Trifecta: Rare Presentation of a Rare Disease” at The ECE 2016, “Hyperinsulinemic Hypoglycemia Post-Bariatric Surgery: Is It More Common Than Anticipated?” at Obesity Updates 2017, and “Prevalence of Primary Hypogonadism Among Male Medical Inpatients with Unexplained Anemia” at the International Congress of Endocrinology 2018. He has also been involved in research on “Undiagnosed Primary Hyperparathyroidism in Pregnancy Resulting in Hypercalcemic Crisis and Uremic Encephalopathy” at AACE Gulf Chapter 2017, and “MDFiNE (Monogenic Diabetes Finder-North East): Pilot of a Novel Digital Search Tool to Enhance Diagnostic Rates for Monogenic Diabetes” at the European Association for the Study of Diabetes (EASD) 2024.
Research & Publications
- Al-Sharefi A, Bilous R. Reversible weakness and encephalopathy while on long-term valproate therapy due to carnitine deficiency. BMJ Case Rep published online 03/09/2015. DOI: 10.1136/bcr-2015-210727.
- Al-Sharefi A, Khan U, Tarigopula G, Peter P, Kamaruddin S, et al. Late Onset Diabetes in Adults (LADA) Masked by Co-Existed Adrenal Failure in the Context of Autoimmune Polyglandular Syndrome 2. J Diabetes Metab Disord Control 2016; 3(3): 00070. DOI: 10.15406/jdmdc.2016.03.00070.
- Tee SA, Bishop D, Al-Sharefi A, Leng O, James RA. Use of TSH-Receptor Antibodies (TRAb) in the assessment of new-onset thyrotoxicosis within the North East of England. Thyroid Research 2017. DOI: 10.1186/s13044-016-0036-8.
- Al-Sharefi A, Quinton R. Re: Male hypogonadism, a treatable yet forgotten cause of unexplained anemia. Blood 2018; 131: 505-514.
- Al-Sharefi A, Quinton R. Hiding in plain sight: A high prevalence of androgen deficiency due to primary hypogonadism among acute medical inpatients with anemia. Clin Endocrinol (Oxf). 2018 Jul 10. DOI: 10.1111/cen.13809. [Epub ahead of print].
- Al-Sharefi A, Perros P, James RA. Pheochromocytoma/Paraganglioma (PHAEO/PG) and adverse clinical outcomes in patients with Neurofibromatosis Type 1 (NF-1). Endocr Connect. 2018 Aug 17. EC-18-0208. DOI: 10.1530/EC-18-0208. [Epub ahead of print].
- Al-Sharefi A, Glenister E, Morris M, Quinton R. Is calcium supplementation always needed in patients with hypoparathyroidism? Clin Endocrinol (Oxf). 2019 Feb 23. DOI: 10.1111/cen.13955. [Epub ahead of print].
- Al-Sharefi A, Quinton R, Roberts G. In Reference to: “Preventing Hypoglycemia Following Treatment of Hyperkalemia in Hospitalized Patients.” J Hosp Med 2019 (In Press).
- Al-Sharefi A, Javaid U, Perros P, Ealing J, Truran P, Nag S, Kamaruddin MS, Abouglilla K, Cains F, Lewis L, James RA. Clinical Presentation and Outcomes of Pheochromocytomas/Paragangliomas (PHAEO/PG) in Neurofibromatosis Type 1 (NF-1). European Endocrinology. 2019; 15(2) [Epub ahead of print].
- Abozaid M, Al-Sharefi A, et al. A rare ophthalmic condition associated with primary hyperparathyroidism (PHPT): sclerochoroidal calcification (SC). Endocrinol Diabetes Metab Case Rep. 2019 Aug 3; 2019(1). DOI: 10.1530/EDM-19-0003.
- Al-Sharefi A, Mohammed A, Abedalaziz A, Jayasena CN. Androgens and anemia: Current trends and future prospects. Front Endocrinol. Oct 2019. DOI: 10.3389/fendo.2019.00754.
- Al-Sharefi A, Wilkes S, Jayasena CN, Quinton R. How to manage low testosterone levels in men: A guide for primary care. Br J Gen Pract. 2020; 70(696): 364-365. Published 2020 Jun 25. DOI: 10.3399/bjgp20X710729.
- Aldibbiat A, Al-Sharefi A. Do Benefits Outweigh Risks for Corticosteroid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in People with Diabetes Mellitus? Int J COPD. Mar 2020; 15: 567-574.
- Al-Sharefi A, Quinton R. Current national and international guidelines for the management of male hypogonadism – helping clinicians navigate variation in diagnostic criteria and treatment recommendations. Endocrinol Metab (Seoul).
- Sherif SA, Newman R, Haboosh S, Al-Sharefi A, Papanikolaou N, Dimakopoulou A, Webber LJ, Abbara A, Franks S, Dhillo WS, Jayasena CN. Investigating the potential of clinical and biochemical markers to differentiate between functional hypothalamic amenorrhea and polycystic ovarian syndrome: A retrospective observational study. Clin Endocrinol (Oxf). Jul 29, 2021. DOI: 10.1111/cen.14571. [Epub ahead of print] PMID: 34323305.
- Sharma A, Ul-Haq Z, Sindi E, Al-Sharefi A, Kamalati T, Dhillo WS, Minhas S, Jayasena CN. Clinical characteristics and comorbidities associated with testosterone prescribing in men. Clin Endocrinol. 2021 (In press).
Expertise
- Diabetes: Type 1 and Type 2 Diabetes, Gestational Diabetes, and Monogenic Diabetes
- Diabetes Technologies: Glucose Sensors, Insulin Pumps, and Artificial Pancreas
- Obesity, Lipids, and Insulin Resistance
- Polycystic Ovarian Syndrome (PCOS) and Hirsutism in Females
- Disorders of the Thyroid and Parathyroid Glands
- Disorders of the Pituitary Gland
- Disorders of the Adrenal Glands
- Testosterone Replacement Therapy and Erectile Dysfunction in Men
Blogs
Hydration and Hormones: Endocrinologists Explain the Important Link
Read more
Hypoparathyroidism: An Uncommon but Manageable Endocrine Disorder
Read more
Type 2 Diabetes: Can the Risk Be Reduced?
Read more
